Table 2

 Irritable bowel syndrome (IBS) symptom scores before and after two weeks of treatment

ParameterBefore melatonin treatment (absolute baseline score)*After melatonin treatment (decrease in score)p Value†
MelatoninPlaceboMelatoninPlacebo
All data are geometric mean (SEM).
*No statistically significant differences between the melatonin and placebo groups for any of the absolute baseline scores.
†Comparisons between the melatonin and placebo groups after two weeks of treatment.
‡Total bowel symptom score >20.0 suggests the presence of significant bowel dysfunction.
Abdominal pain4.05 (0.28)3.85 (0.32)2.35 (0.30)0.70 (0.25)<0.001
Abdominal distension4.00 (0.36)3.15 (0.38)1.05 (0.38)0.15 (0.29)0.069
Frequency of defecation3.25 (0.32)3.15 (0.43)1.85 (0.39)0.85 (0.37)0.070
Stool type6.15 (0.60)6.25 (0.54)0.65 (0.60)0.55 (0.37)NS
Abnormal sensation of defecation7.10 (1.02)7.70 (0.95)1.30 (0.80)1.35 (0.65)NS
Quality of life5.80 (0.84)5.45 (0.65)1.25 (0.20)0.95 (0.17)NS
Total bowel symptom score‡30.35 (1.84)29.55 (1.93)7.30 (1.37)3.95 (1.25)0.078